CDR-Life is a biopharmaceutical company that develops tumor targeted immunotherapies. The company has a uniquely powerful platform technology to target intracellular tumor antigens with highly potent and specific T cell engagers.
Products, services, technology
CDR-Life’s lead programs include novel immunotherapies targeting intracellular cancer-related proteins for superior tumor-selectivity and more durable efficacy. The company’s portfolio contains several first-in-class immunotherapies against solid and liquid tumors.
CDR-Life has a strategic partnership with a global pharmaceutical company and continues to partner with leading companies that share our vision of bringing highly innovative antibody therapies to patients.